National Cancer Diagnosis Audit
Coronavirus (COVID-19)
We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.
Get involved
The NCDA data collection is currently closed. A template for practice internal use is available below to support continuous audit between national cycles.
Audit to improve care
The NCDA helps us to better understand pathways to cancer diagnosis, identifies good practice and supports targeted quality improvement
How does the audit work?
The NCDA provides an evidence-based audit tool to review pathways to cancer diagnosis, benchmark current practice and identify areas for improvement.
Insights & Quality Improvement
Most patients are referred promptly, but some experience avoidable delay. Practices identify referral processes, safety netting and screening uptake as areas for QI.
Information for Patients
The audit uses data from patients collected as part of their routine care to better understand how cancers are diagnosed.
We’re now on twitter.
|
This National Cancer Diagnosis Audit is operationally managed by Cancer Research UK, but is a broad partnership that involves support and input from: The Royal College of General Practitioners, Macmillan Cancer Support, Public Health England (specifically the National Cancer Registration and Analysis Service), NHS England, Public Health Scotland, Scottish government, Public Health Wales (specifically the Welsh Cancer Intelligence and Surveillance Unit), the Wales Cancer Network, the Northern Ireland Cancer Registry (at Queen’s University Belfast), as well as our patient representatives and academic partners.
